CDD MatchGrant Program

The Center for Drug Discovery (CDD) established a MatchGrant Award program to advance translational small-molecule drug discovery research at Washington University. CDD offers a full suite of preclinical drug discovery services and know-how. Capabilities range from drug lead finding utilizing the High Throughput Screening Core to Medicinal Chemistry-driven drug lead optimization, ADME profiling, and in vivopharmacokinetics for proof-of-concept in vivo pharmacology studies, intellectual property (patent) filing, and drug development.


MatchGrants are awards for up to $15,000. The award covers 50% of CDD-facilitated work. The applicant is expected to provide the remaining 50% in an amount equal to the award.  For example, a researcher awarded a grant equal to $15,000 will provide $7,500 from another fund, CDD $7,500.

Eligibility criteria. Investigators with a faculty appointment at Washington University.

Submission deadline & notification. Applications are accepted on a rolling basis with notification within 4 weeks.

Award term. The funds are available for 1 year.

Expectation. The MatchGrant is viewed as a “hand-up” to generate preliminary data to enable successful extramural funding.

Reporting. Final reports are required upon project completion. Investigators will be surveyed annually for 3 years after the award expires to capture the return on investment (e.g., publications, grant submissions, other outcomes) for the funding program.

Pre-consultation. Applicants are strongly advised to consult with CDD prior to submission.

Application process:

  • Download application form here.
  • Submit completed application along with a current Biosketch or CV to Ron Dolle.


MatchGrant applications are accepted on a rolling basis. Apply now.